MiRNA signature predicts the response of patients with advanced lung adenocarcinoma to platinum-based treatment.
Xu X, Yu S, Sun W, Qin X, Chen Y, Zhou L, Lou R, Dong S, Shen B, Wu J, Zang J, Cao H, Shi M, Zhang Q, Feng J.
Xu X, et al. Among authors: sun w.
J Cancer Res Clin Oncol. 2018 Mar;144(3):431-438. doi: 10.1007/s00432-017-2562-8. Epub 2017 Dec 29.
J Cancer Res Clin Oncol. 2018.
PMID: 29288364